Scientific Advisory Board

Comparative Effectiveness Research Advisory Committee

Al Benson, III, MD, FACp, Associate Director for Clinical Investigations, Robert H. Lurie Comprehensive Cancer Center

Amy Abernethy, MD, Director, Duke Cancer Care Research Program, Duke University School of Medicine

Robert Bast, MD, Vice President for Translational Research, MD Anderson Cancer Center

Michael Caligiuri, MD, Director, Ohio State University Comprehensive Cancer Center

William Dalton, MD, Ph.D, CEO & Director, H. Lee Moffitt Cancer Center and Research Institute

William Nelson, MD, Ph.D, Director, Sidney Kimmel Comprehensive Cancer Center at JohnsHopkins University

Daniel Sargent, Ph.D, Professor of Biostatistics, Professor of Oncology, Mayo Clinic

Ethan Basch, MD, MSc, Medical Oncologist & Health Services Researcher, Department of Medicine and Department of Epidemiology, Memorial Sloan-Kettering Cancer Center

Food and Drug Administration Advisory Committee

Ed Benz, MD, President & CEO, Dana-Farber Cancer Institute

Michael Caligiuri, MD, Director, Ohio State University Comprehensive Cancer Center

Bruce Chabner, MD, Clinical Director, Massachusetts General Hospital Cancer Center

John Marshall, MD, Chief, Division of Hematology/Oncology, Georgetown University LombardiComprehensive Cancer Center

Howard Scher, MD, Chief, Gernitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center

Richard Schilsky, MD, Chief Medical Officer, The American Society of Clinical Oncology

Stephen Spielberg, MD, Ph.D, Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration

Robert Young, MD, President, RCYMedicine